Journal profile · Biotechnology & Applied Microbiology
Minerva Biotecnologica
ISSN 1120-4826 · eISSN 1827-160X · Edizioni Minerva Medica S.p.A. · ITALY · Quarterly · Founded 1989
Minerva Biotecnologica: impact factor 0.92; subscription journal; review over 12 weeks (community reports); community-reported acceptance: easy; 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Minerva Biotecnologica is published by Edizioni Minerva Medica S.p.A.. By OpenAlex counts of its recent articles, its largest topics are Hepatitis C virus research, Helicobacter pylori-related gastroenterology studies and Molecular Biology Techniques and Applications, together about 23% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Minerva Biotecnologica publishes scientific papers on biotechnology and molecular biology. Manuscripts may be submitted in the form of editorials, original articles, review articles, special articles and letters to the Editor. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work.
Source: LetPub
Research area (LetPub): Biotechnology & Applied Microbiology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hepatitis C virus researchMedicine8%
- Helicobacter pylori-related gastroenterology studiesMedicine8%
- Molecular Biology Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology7.1%
- Immunotherapy and Immune ResponsesImmunology and Microbiology6.2%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology5.3%
- Monoclonal and Polyclonal Antibodies ResearchMedicine5.3%
- Viral gastroenteritis research and epidemiologyMedicine4.4%
- Advanced Biosensing Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Biotechnology | Q3 | 181/282 | 35th |
| Applied Microbiology and Biotechnology | Q3 | 74/113 | 34th |
| Bioengineering | Q4 | 112/148 | 24th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.92LetPub ·
- CiteScore 2026-06
- 2LetPub ·
- SJR 2026-06
- 0.26LetPub ·
- SNIP 2026-06
- 0.4LetPub ·
- h-index
- 16LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 20OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 109 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 4 |
| 2025 | 0 | 0 | 19 |
| 2024 | 0 | 0 | 22 |
| 2023 | 0 | 0 | 41 |
| 2022 | 0 | 0 | 80 |
| 2021 | 8 | 0 | 123 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Edizioni Minerva Medica S.p.A.
- Country or region
- ITALY
- Language
- Multi-Language
- Frequency
- Quarterly
- Founded
- 1989
- ISSN
- 1120-4826
- Electronic ISSN
- 1827-160X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Minerva Biotecnologica
What is the impact factor of Minerva Biotecnologica?
The latest impact factor listed by LetPub is 0.92; CiteScore 2, h-index 14.
How long does peer review take at Minerva Biotecnologica?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Minerva Biotecnologica?
According to LetPub and DOAJ records, Minerva Biotecnologica is indexed in Scopus.
Is Minerva Biotecnologica open access, and what is the APC?
Minerva Biotecnologica is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .